Established and upcoming new options in medical therapy for benign prostatic hyperplasia;Medikamentöse therapie des benignen prostatasyndroms: Alles wieder im fluss?

MMW-Fortschritte der Medizin

Volumn 151, Issue 41, 2009, Pages 33-36

  Schlenker, Boris ^a   Beer, André Michael ^b   Gratzke, Christian ^a   Tilki, Derya ^a   Seitz, Michael ^a   Stief, Christian G ^a   Reich, Oliver ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

1 blockers; 5 reductase inhibitors; Antimuscarinic agents; BPH; Phosphodiesterase type 5 inhibitors; Plant extracts

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PHOSPHODIESTERASE INHIBITOR; PROSTAFINK; PROSTAGUTT; SABAL EXTRACT; SILDENAFIL; TADALAFIL; TAMSULOSIN; TERAZOSIN; UNCLASSIFIED DRUG; URTICA EXTRACT; VARDENAFIL;

ALGORITHM; DISEASE COURSE; ERECTILE DYSFUNCTION; HUMAN; PHARMACY; PROSTATE; PROSTATE HYPERTROPHY; RECEPTOR BLOCKING; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

5-ALPHA REDUCTASE INHIBITORS; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ALGORITHMS; DRUG THERAPY, COMBINATION; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PHOSPHODIESTERASE INHIBITORS; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC HYPERPLASIA; TREATMENT OUTCOME; URINARY BLADDER NECK OBSTRUCTION;

EID: 70350509584     PISSN: 14383276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)